Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $136.50
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been assigned an average rating of “Buy” from the ten brokerages that are covering the firm, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year […]
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been assigned an average rating of “Buy” from the ten brokerages that are covering the firm, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year […]
